Trial · NCT01811472
Results by group123
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 123
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in Percentage of Fat in the Liver as Assessed Using MRI at Week 24 | Placebo | 0.00 | 95% Confidence Interval -1.63 to 1.63 | Percentage of liver fat | |
| Change From Baseline in Percentage of Fat in the Liver as Assessed Using MRI at Week 24 | Pradigastat (LCQ908) 5mg/10mg | -1.68 | 95% Confidence Interval -3.93 to 0.56 | Percentage of liver fat | |
| Change From Baseline in Percentage of Fat in the Liver as Assessed Using MRI at Week 24 | Pradigastat (LCQ908) 10mg/20mg | -2.89 | 95% Confidence Interval -4.59 to -1.18 | Percentage of liver fat | |
| Change From Baseline in Percentage of Fat in the Liver as Assessed Using MRI at Week 12 | Placebo | -0.80 | 90% Confidence Interval -2.31 to 0.72 | Percentage of liver fat | |
| Change From Baseline in Percentage of Fat in the Liver as Assessed Using MRI at Week 12 | Pradigastat (LCQ908) 5mg/10mg | -1.71 | 90% Confidence Interval -3.79 to 0.37 | Percentage of liver fat | |
| Change From Baseline in Percentage of Fat in the Liver as Assessed Using MRI at Week 12 | Pradigastat (LCQ908) 10mg/20mg | -2.98 | 90% Confidence Interval -4.55 to -1.42 | Percentage of liver fat | |
| Percentage of Responders at Week 12 | Placebo | At least 30% reduction in percent liver fat | 10.00 | Percentage of responders | |
| Percentage of Responders at Week 12 | Pradigastat (LCQ908) 5mg/10mg | At least 30% reduction in percent liver fat | 18.18 | Percentage of responders | |
| Percentage of Responders at Week 12 | Pradigastat (LCQ908) 10mg/20mg | At least 30% reduction in percent liver fat | 31.58 | Percentage of responders | |
| Percentage of Responders at Week 12 | Placebo | At least 50% reduction in percent liver fat | 5.00 | Percentage of responders | |
| Percentage of Responders at Week 12 | Pradigastat (LCQ908) 5mg/10mg | At least 50% reduction in percent liver fat | 0.00 | Percentage of responders | |
| Percentage of Responders at Week 12 | Pradigastat (LCQ908) 10mg/20mg | At least 50% reduction in percent liver fat | 21.05 | Percentage of responders | |
| Percentage of Responders at Week 12 | Placebo | Liver fat content < 10% | 5.00 | Percentage of responders | |
| Percentage of Responders at Week 12 | Pradigastat (LCQ908) 5mg/10mg | Liver fat content < 10% | 18.18 | Percentage of responders | |
| Percentage of Responders at Week 12 | Pradigastat (LCQ908) 10mg/20mg | Liver fat content < 10% | 36.84 | Percentage of responders | |
| Percentage of Responders at Week 12 | Placebo | Liver fat content <5.6% | 0.00 | Percentage of responders | |
| Percentage of Responders at Week 12 | Pradigastat (LCQ908) 5mg/10mg | Liver fat content <5.6% | 0.00 | Percentage of responders | |
| Percentage of Responders at Week 12 | Pradigastat (LCQ908) 10mg/20mg | Liver fat content <5.6% | 21.05 | Percentage of responders | |
| Percentage of Responders at Week 24 | Placebo | At least 30% reduction in percent liver fat | 10.53 | Percentage of responders | |
| Percentage of Responders at Week 24 | Pradigastat (LCQ908) 5mg/10mg | At least 30% reduction in percent liver fat | 30.00 | Percentage of responders |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01811472/results